Skip to main content

Human Papillomavirus: Vaccination

Question for Department of Health

UIN 218969, tabled on 16 December 2014

To ask the Secretary of State for Health, when he expects the Joint Committee on Vaccination and Innoculation to make a recommendation on whether all adolescent boys should be included in the national HPV vaccination programme.

Answered on

5 January 2015

The Joint Committee on Vaccination and Immunisation (JCVI), the body that advises the government on all immunisation matters has set up a human papillomavirus (HPV) sub-committee to consider a number of key issues on HPV vaccination, including the routine vaccination of adolescent boys.

The HPV sub-committee will report its findings to the JCVI following consideration of work modelling the impact and cost-effectiveness of extending HPV vaccination to adolescent boys. We are advised that it is currently anticipated that a model being developed at Warwick University can be presented to the HPV sub-committee in the second half of 2015. A separate model being developed by Public Health England may not be completed until early 2017.

We are furthermore advised that the JCVI and sub-committee may need to consider both studies before taking a final view on the impact and cost-effectiveness of extending HPV vaccination to adolescent boys and may therefore not be in a position to do so before early 2017.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.